Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Radiation Oncology
Published in: Radiation Oncology 1/2011

Open Access 01-12-2011 | Research

Volumetric modulated arc planning for lung stereotactic body radiotherapy using conventional and unflattened photon beams: a dosimetric comparison with 3D technique

Authors: Geoffrey G Zhang, Lichung Ku, Thomas J Dilling, Craig W Stevens, Ray R Zhang, Weiqi Li, Vladimir Feygelman

Published in: Radiation Oncology | Issue 1/2011

Login to get access

Abstract

Purpose

Frequently, three-dimensional (3D) conformal beams are used in lung cancer stereotactic body radiotherapy (SBRT). Recently, volumetric modulated arc therapy (VMAT) was introduced as a new treatment modality. VMAT techniques shorten delivery time, reducing the possibility of intrafraction target motion. However dose distributions can be quite different from standard 3D therapy. This study quantifies those differences, with focus on VMAT plans using unflattened photon beams.

Methods

A total of 15 lung cancer patients previously treated with 3D or VMAT SBRT were randomly selected. For each patient, non-coplanar 3D, coplanar and non-coplanar VMAT and flattening filter free VMAT (FFF-VMAT) plans were generated to meet the same objectives with 50 Gy covering 95% of the PTV. Two dynamic arcs were used in each VMAT plan. The couch was set at ± 5° to the 0° straight position for the two non-coplanar arcs. Pinnacle version 9.0 (Philips Radiation Oncology, Fitchburg WI) treatment planning system with VMAT capabilities was used. We analyzed the conformity index (CI), which is the ratio of the total volume receiving at least the prescription dose to the target volume receiving at least the prescription dose; the conformity number (CN) which is the ratio of the target coverage to CI; and the gradient index (GI) which is the ratio of the volume of 50% of the prescription isodose to the volume of the prescription isodose; as well as the V20, V5, and mean lung dose (MLD). Paired non-parametric analysis of variance tests with post-tests were performed to examine the statistical significance of the differences of the dosimetric indices.

Results

Dosimetric indices CI, CN and MLD all show statistically significant improvement for all studied VMAT techniques compared with 3D plans (p < 0.05). V5 and V20 show statistically significant improvement for the FFF-VMAT plans compared with 3D (p < 0.001). GI is improved for the FFF-VMAT and the non-coplanar VMAT plans (p < 0.01 and p < 0.05 respectively) while the coplanar VMAT plans do not show significant difference compared to 3D plans. Dose to the target is typically more homogeneous in FFF-VMAT plans. FFF-VMAT plans require more monitor units than 3D or non-coplanar VMAT ones.

Conclusion

Besides the advantage of faster delivery times, VMAT plans demonstrated better conformity to target, sharper dose fall-off in normal tissues and lower dose to normal lung than the 3D plans for lung SBRT. More monitor units are often required for FFF-VMAT plans.
Appendix
Available only for authorised users
Literature
1.
Nagata Y, Takayama K, Matsuo Y, Norihisa Y, Mizowaki T, Sakamoto T, Sakamoto M, Mitsumori M, Shibuya K, Araki N, et al.: Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys 2005, 63: 1427-1431. 10.1016/j.ijrobp.2005.05.034CrossRefPubMed
2.
Timmerman R, Paulus R, Galvin J, Michalski J, Straube W, Bradley J, Fakiris A, Bezjak A, Videtic G, Johnstone D, et al.: Stereotactic body radiation therapy for inoperable early stage lung cancer. J Am Med Assoc 2010, 303: 1070-1076. 10.1001/jama.2010.261CrossRef
3.
Xia T, Li H, Sun Q, Wang Y, Fan N, Yu Y, Li P, Chang JY: Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable Stage I/II non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2006, 66: 117-125. 10.1016/j.ijrobp.2006.04.013CrossRefPubMed
4.
Timmerman RD, Forster KM, Cho LC: Extracranial Stereotactic Radiation Delivery. Seminars in radiation oncology 2005, 15: 202-207. 10.1016/j.semradonc.2005.01.006CrossRefPubMed
5.
Fogliata A, Clivio A, Nicolini G, Vanetti E, Cozzi L: Intensity modulation with photons for benign intracranial tumours: A planning comparison of volumetric single arc, helical arc and fixed gantry techniques. Radiother oncol 2008, 89: 254-262. 10.1016/j.radonc.2008.07.021CrossRefPubMed
6.
Kjær-Kristoffersen F, Ohlhues L, Medin J, Korreman S: RapidArc volumetric modulated therapy planning for prostate cancer patients. Acta Oncol 2009, 48: 227-232. 10.1080/02841860802266748CrossRefPubMed
7.
Lagerwaard FJ, Meijer OWM, van der Hoorn EAP, Verbakel WFAR, Slotman BJ, Senan S: Volumetric Modulated Arc Radiotherapy for Vestibular Schwannomas. Int J Radiat Oncol Biol Phys 2009, 74: 610-615. 10.1016/j.ijrobp.2008.12.076CrossRefPubMed
8.
Matuszak MM, Yan D, Grills I, Martinez A: Clinical Applications of Volumetric Modulated Arc Therapy. Int J Radiat Oncol Biol Phys 2010, 77: 608-616. 10.1016/j.ijrobp.2009.08.032CrossRefPubMed
9.
Verbakel WFAR, Senan S, Cuijpers JP, Slotman BJ, Lagerwaard FJ: Rapid delivery of stereotactic radiotherapy for peripheral lung tumors using volumetric intensity-modulated arcs. Radiother Oncol 2009, 93: 122-124. 10.1016/j.radonc.2009.05.020CrossRefPubMed
10.
Holt A, van Vliet-Vroegindeweij C, Mans A, Belderbos JS, Damen EMF: Volumetric-modulated arc therapy for stereotactic body radiotherapy of lung tumors: a comparison with intensity-modulated radiotherapy techniques. Int J Radiat Oncol Biol Phys 2011, in press.
11.
Feygelman V, Zhang G, Stevens C: Initial dosimetric evaluation of SmartArc-a novel VMAT treatment planning module implemented in a multi-vendor environment. J Appl Clin Med Phy 2010, 11: 99-116.
12.
Dhabaan A, Elder E, Schreibmann E, Crocker I, Curran WJ, Oyesiku NM, Shu H-K, Fox T: Dosimetric performance of the new high-definition multileaf collimator for intracranial stereotactic radiosurgery. J Appl Clin Med Phy 2010, 11: 197-211.
13.
Riet Av, Mak ACA, Moerland MA, Elders LH, van der Zee W: A conformation number to quantify the degree of conformality in brachytherapy and external beam irradiation: Application to the prostate. Int J Radiat Oncol Biol Phys 1997, 37: 731-736. 10.1016/S0360-3016(96)00601-3CrossRef
14.
Paddick I, Lippitz B: A simple dose gradient measurement tool to complement the conformity index. J Neurosurg 2006, 105: 194-201.PubMed
15.
Graham MV, Purdy JA, Emami B, Harms W, Bosch W, Lockett MA, Perez CA: Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 1999, 45: 323-329.CrossRefPubMed
16.
Bradley J, Graham MV, Winter K, Purdy JA, Komaki R, Roa WH, Ryu JK, Bosch W, Emami B: Toxicity and outcome results of RTOG 9311: A phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma. Int j radiat oncol biol phys 2005, 61: 318-328. 10.1016/j.ijrobp.2004.06.260CrossRefPubMed
17.
Allen AM, Czerminska M, Jänne PA, Sugarbaker DJ, Bueno R, Harris JR, Court L, Baldini EH: Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma. Int J Radiat Oncol Biol Phys 2006, 65: 640-645. 10.1016/j.ijrobp.2006.03.012CrossRefPubMed
18.
Wang S, Liao Z, Wei X, Liu HH, Tucker SL, Hu C, Mohan R, Cox JD, Komaki R: Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT). Int J Radiat Oncol Biol Phys 2006, 66: 1399-1407. 10.1016/j.ijrobp.2006.07.1337CrossRefPubMed
19.
Seppenwoolde Y, Lebesque JV, de Jaeger K, Belderbos JSA, Boersma LJ, Schilstra C, Henning GT, Hayman JA, Martel MK, Ten Haken RK: Comparing different NTCP models that predict the incidence of radiation pneumonitis. Int J Radiat Oncol Biol Phys 2003, 55: 724-735. 10.1016/S0360-3016(02)03986-XCrossRefPubMed
20.
Niemierko A: Reporting and analyzing dose distributions: A concept of equivalent uniform dose. Med Phys 1997, 24: 103-110. 10.1118/1.598063CrossRefPubMed
21.
Wu Q, Mohan R, Niemierko A, Schmidt-Ullrich R: Optimization of intensity-modulated radiotherapy plans based on the equivalent uniform dose. Int J Radiat Oncol Biol Phys 2002, 52: 224-235. 10.1016/S0360-3016(01)02585-8CrossRefPubMed
22.
Verellen D, Vanhavere F: Risk assessment of radiation-induced malignancies based on whole-body equivalent dose estimates for IMRT treatment in the head and neck region. Radiother Oncol 1999, 53: 199-203. 10.1016/S0167-8140(99)00079-1CrossRefPubMed
23.
McGrath SD, Matuszak MM, Yan D, Kestin LL, Martinez AA, Grills IS: Volumetric modulated arc therapy for delivery of hypofractionated stereotactic lung radiotherapy: A dosimetric and treatment efficiency analysis. Radiother Oncol 2010, 95: 153-157. 10.1016/j.radonc.2009.12.039CrossRefPubMed
24.
Chan OSH, Lee MCH, Hung AWM, Chang ATY, Yeung RMW, Lee AWM: The superiority of hybrid-volumetric arc therapy (VMAT) technique over double arcs VMAT and 3D-conformal technique in the treatment of locally advanced non-small cell lung cancer-A planning study. Radiother Oncol 2011, in press.
25.
Hong LX, Garg M, Lasala P, Kim M, Mah D, Chen C, Yaparpalvi R, Mynampati D, Guha C, Kalnicki S: Linear accelerator based single fraction stereotactic radiosurgery: sharp dose fall off in normal tissues depends on dose inhomogeneity in tumor. Int J Radiat Oncol Biol Phys 2010, 78: S794.CrossRef
26.
Cashmore J, Ramtohul M, Ford D: Lowering whole-body radiation doses in pediatric intensity-modulated radiotherapy through the use of unflattened photon beams. Int j radiat oncol biol phys 2011, 80: 1220-1227. 10.1016/j.ijrobp.2010.10.002CrossRefPubMed
27.
Buckey CR, Stathakis S, Papanikolaou N: The inter- and intrafraction reproducibilities of three common IMRT delivery techniques. Med Phys 2010, 37: 4854-4860. 10.1118/1.3476413CrossRefPubMed
Metadata
Title
Volumetric modulated arc planning for lung stereotactic body radiotherapy using conventional and unflattened photon beams: a dosimetric comparison with 3D technique
Authors
Geoffrey G Zhang
Lichung Ku
Thomas J Dilling
Craig W Stevens
Ray R Zhang
Weiqi Li
Vladimir Feygelman
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Radiation Oncology / Issue 1/2011
Electronic ISSN: 1748-717X
DOI
https://doi.org/10.1186/1748-717X-6-152

Other articles of this Issue 1/2011

Radiation Oncology 1/2011 Go to the issue

Research

Dosimetric evaluation of Acuros XB Advanced Dose Calculation algorithm in heterogeneous media

Research

Acute toxicity in prostate cancer patients treated with and without image-guided radiotherapy

Research

Fractionated stereotactic conformal radiotherapy for large benign skull base meningiomas

Research

Effect of neoadjuvant chemoradiation and postoperative radiotherapy on expression of heat shock protein 70 (HSP70) in head and neck vessels

Review

Radiation induced temporal lobe necrosis in patients with nasopharyngeal carcinoma: a review of new avenues in its management

Research

Phospho-ERK and AKT status, but not KRAS mutation status, are associated with outcomes in rectal cancer treated with chemoradiotherapy